Siemens Healthineers to buy US cancer specialist for $16.4 bn
Siemens Healthineers, the German conglomerate's medical devices arm, said Sunday it has agreed to buy US cancer treatment specialist Varian for $16.4 billion.
Aug 2, 2020
0
4
Siemens Healthineers, the German conglomerate's medical devices arm, said Sunday it has agreed to buy US cancer treatment specialist Varian for $16.4 billion.
Aug 2, 2020
0
4
A partnership that would bypass the drug industry to sell a potential vaccine against the new coronavirus has been formed by a laboratory at Imperial College London.
Jun 9, 2020
0
3
Swiss pharma giant Novartis on Tuesday reported higher profits for the first quarter as customers rushing to buy treatments during the coronavirus outbreak boosted the bottom line.
Apr 28, 2020
0
2
Physically, older people are among those most vulnerable to the coronavirus.
Apr 15, 2020
0
2
A growing demand for healthier drink options is putting the hospitality sector on notice as patrons increasingly shun alcohol and soft drinks in favor of probiotics and super juices.
Jan 24, 2020
0
1
Novo Nordisk said Friday that its new treatment for adults who suffer from diabetes drove sales and profits higher, but the world's top manufacturer of insulin still faced difficulties in the key US market.
Nov 1, 2019
0
1
(HealthDay)—Patients with end-stage kidney disease who undergo dialysis at for-profit institutions are less likely to receive a kidney transplant, according to a study published online Sept. 10 in the Journal of the American ...
Oct 15, 2019
0
2
The world's four major tobacco companies—two of which have HQs in the UK—are paying minimal UK corporation tax despite enormous reported profits, according to findings from new research published in the Journal of Public ...
Feb 6, 2019
0
4
Swiss pharmaceuticals giant Novartis said Wednesday that the sale of its stake in a joint venture with Britain's GlaxoSmithKlein helped boost net profit last year by 64 percent.
Jan 30, 2019
0
0
Danish drugmaker Novo Nordisk, the world's leading insulin provider, on Wednesday reported a six percent jump in net profit in the first quarter, as the global onslaught of diabetes continued to grow.
May 2, 2018
0
4